DENVER, April 09, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial ...
For its fiscal year ended May 31, 2026, the Company reconfirms its guidance to achieve; adjusted EBITDA of $62 million to $72 million, representing growth of 13% to 31% as compared to fiscal year 2025 ...
Honeywell (NASDAQ: HON), and 3M (NYSE: MMM) have all pulled back sharply over the past month. Each just reported Q4 2025 earnings, and each tells a very different story about what “dip” actually means ...
Q4 FY26 Net Sales Increased 2.7% to $248.0 million vs. Q4 FY25 FY26 Net Sales Increased 2.4% to $697.1 million vs. FY25Announces New $40 million ...
Revenue in the fourth quarter of 2025 was $6.07 million compared to $10.27 million in the fourth quarter of 2024, due to the termination of the license of $2.9 million. For the full year 2025, revenue ...
Q4 2025 revenues were $13.4 million, up 29.7% from Q4 2024. This was an all-time quarterly record for the Company. Full year 2025 revenues were ...
AbbVie (ABBV) has issued a preliminary financial update, lowering its earnings expectations for the first quarter and full year of 2026. The revision stems from $744 million in pre-tax expenses ...
In 2025, we made significant strides towards advancing DrugSorb-ATR - a two-time U.S. Food and Drug Administration (FDA) Breakthrough Device - through the FDA De Novo submission process to reduce ...
Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Gordon Scott has been an active investor and ...
Today, Zacks Investment Ideas feature highlights Adobe’s ADBE and Microsoft MSFT. 2 Great Tech Stocks to Buy Now, Down -65% ...
StockStory.org on MSN
FactSet (NYSE:FDS) beats Q1 CY2026 sales expectations, stock soars
Financial data provider FactSet (NYSE:FDS) announced in Q1 CY2026, with sales up 7.1% year on year to $611 million. The ...
Relative to its peer companies, Merck KGaA has a compelling valuation from which to realize its upside potential through its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results